3 Year Absolute Returns
68.10% ↑
NAV (₹) on 15 Sep 2026
38.89
1 Day NAV Change
-0.89%
Risk Level
Very High Risk
Rating
-
Tata India Pharma & HealthCare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Tata Asset Management Ltd.. Launched on 04 Dec 2015, investors can start with a minimum ... Read more
AUM
₹ 1,565.28 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 60.78% |
| Hospitals & Medical Services | 31.05% |
| Agro Chemicals/Pesticides | 5.55% |
| Personal Care | 1.09% |
| Chemicals - Speciality | 0.52% |
| Finance - Life Insurance | 0.50% |
| Cash | 0.32% |
| CBLO/Reverse Repo | 0.19% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | 8.43% | ₹ 132.02 | Pharmaceuticals |
| HEALTHCARE GLOBAL ENTERPRISES LTD | 6.30% | ₹ 98.56 | Hospitals & Medical Services |
| DIVI LABORATORIES LTD | 5.65% | ₹ 88.49 | Pharmaceuticals |
| ABBOTT INDIA LTD | 5.44% | ₹ 85.11 | Pharmaceuticals |
| RAINBOW CHILDRENS MEDICARE LTD | 4.47% | ₹ 70.04 | Hospitals & Medical Services |
| APOLLO HOSPITALS ENTERPRISE LTD | 4.32% | ₹ 67.64 | Hospitals & Medical Services |
| CIPLA LTD | 4.27% | ₹ 66.78 | Pharmaceuticals |
| DR REDDYS LABORATORIES LTD | 4.21% | ₹ 65.84 | Pharmaceuticals |
| MAX HEALTHCARE INSTITUTE LTD | 3.80% | ₹ 59.55 | Hospitals & Medical Services |
| FORTIS HEALTHCARE LTD | 3.30% | ₹ 51.63 | Hospitals & Medical Services |
| LUPIN LTD | 3.26% | ₹ 51.09 | Pharmaceuticals |
| SYNGENE INTERNATIONAL LTD | 3.02% | ₹ 47.28 | Pharmaceuticals |
| BAYER CROPSCIENCE LTD | 3.01% | ₹ 47.18 | Agro Chemicals/Pesticides |
| PFIZER LTD | 2.92% | ₹ 45.76 | Pharmaceuticals |
| MANKIND PHARMA LTD | 2.91% | ₹ 45.58 | Pharmaceuticals |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | 2.72% | ₹ 42.63 | Pharmaceuticals |
| PROCTER & GAMBLE HEALTH LTD | 2.51% | ₹ 39.22 | Pharmaceuticals |
| SAI LIFE SCIENCES LTD | 2.41% | ₹ 37.67 | Pharmaceuticals |
| ALKEM LABORATORIES LTD | 2.35% | ₹ 36.80 | Pharmaceuticals |
| ANTHEM BIOSCIENCES LTD | 2.14% | ₹ 33.44 | Pharmaceuticals |
| FDC LTD | 2.10% | ₹ 32.90 | Pharmaceuticals |
| GLOBAL HEALTH LTD | 1.68% | ₹ 26.31 | Hospitals & Medical Services |
| DR. LAL PATH LABS LTD | 1.66% | ₹ 25.97 | Hospitals & Medical Services |
| ASTER DM QUALITY CARE LTD | 1.59% | ₹ 24.93 | Hospitals & Medical Services |
| SUMITOMO CHEMICAL INDIA LTD | 1.59% | ₹ 24.84 | Agro Chemicals/Pesticides |
| AJANTA PHARMA LTD | 1.57% | ₹ 24.51 | Pharmaceuticals |
| ACUTAAS CHEMICALS LTD | 1.48% | ₹ 23.20 | Pharmaceuticals |
| MANIPAL HEALTH ENTERPRISES LTD | 1.24% | ₹ 19.34 | Hospitals & Medical Services |
| METROPOLIS HEALTHCARE LTD | 1.11% | ₹ 17.32 | Hospitals & Medical Services |
| GILLETTE INDIA LTD | 1.09% | ₹ 17.03 | Personal Care |
| BIOCON LTD | 0.99% | ₹ 15.51 | Pharmaceuticals |
| PI INDUSTRIES LTD | 0.95% | ₹ 14.95 | Agro Chemicals/Pesticides |
| IPCA LABORATORIES LTD | 0.90% | ₹ 14.13 | Pharmaceuticals |
| MOLBIO DIAGNOSTICS LTD | 0.87% | ₹ 13.67 | Hospitals & Medical Services |
| DR. AGARWALS HEALTH CARE LTD | 0.71% | ₹ 11.05 | Hospitals & Medical Services |
| SYMBIOTEC PHARMALAB LTD | 0.64% | ₹ 10 | Pharmaceuticals |
| SANOFI CONSUMER HEALTHCARE INDIA LTD | 0.52% | ₹ 8.21 | Chemicals - Speciality |
| HDFC LIFE INSURANCE CO. LTD | 0.50% | ₹ 7.88 | Finance - Life Insurance |
| ZIM LABORATORIES LTD | 0.49% | ₹ 7.74 | Pharmaceuticals |
| CASH / NET CURRENT ASSET | 0.32% | ₹ 4.60 | Others |
| JUBILANT PHARMOVA LTD | 0.25% | ₹ 3.97 | Pharmaceuticals |
| REPO | 0.19% | ₹ 3.03 | Others |
| TORRENT PHARMACEUTICALS LTD | 0.12% | ₹ 1.89 | Pharmaceuticals |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 9.20% | 7.98% | 3.61% | 18.90% |
| Category returns | 3.34% | 3.85% | 2.63% | 19.22% |
The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29 | 18.43% | 142.90% | 0.00% | ₹11,478 | 1.78% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Tata India Pharma & HealthCare Fund - Direct Plan
Sector
Direct
|
₹37.63 | 4.47% | 62.64% | 86.81% | ₹1,565 | 1.00% |
Very High
|
|
Tata India Pharma & HealthCare Fund - Direct Plan
Sector
Direct
|
₹37.63 | 4.47% | 62.64% | 86.81% | ₹1,565 | 1.00% |
Very High
|
|
Tata India Pharma & HealthCare Fund
Sector
Regular
|
₹32.89 | 6.45% | 60.89% | 79.32% | ₹1,565 | 2.32% |
Very High
|
|
Tata India Pharma & HealthCare Fund
Sector
Regular
|
₹31.63 | 2.38% | 54.73% | 72.46% | ₹1,565 | 2.32% |
Very High
|
|
Tata India Pharma & HealthCare Fund
Sector
Regular
|
₹31.63 | 2.38% | 54.73% | 72.46% | ₹1,565 | 2.32% |
Very High
|
|
Tata Mid Cap Fund - Direct Plan
Diversified
Direct
|
₹518.33 | 4.58% | 49.17% | 94.31% | ₹6,240 | 0.87% |
Very High
|
|
Tata Resources & Energy Fund - Direct Plan
Sector
Direct
|
₹56.47 | 6.01% | 48.77% | 74.49% | ₹1,409 | 0.84% |
Very High
|
|
Tata India Consumer Fund - Direct Plan
Sector
Direct
|
₹54.19 | 2.14% | 47.81% | 85.29% | ₹2,901 | 0.92% |
Very High
|
|
Tata Dividend Yield Fund - Direct Plan
Diversified
Direct
|
₹21.16 | 8.72% | 46.86% | 85.87% | ₹1,156 | 0.76% |
Very High
|
|
Tata Dividend Yield Fund - Direct Plan
Diversified
Direct
|
₹21.16 | 8.72% | 46.86% | 85.87% | ₹1,156 | 0.76% |
Very High
|
What is the current NAV of Tata India Pharma & HealthCare Fund - Direct Plan Growth?
What is the fund size (AUM) of Tata India Pharma & HealthCare Fund - Direct Plan Growth?
What are the historical returns of Tata India Pharma & HealthCare Fund - Direct Plan Growth?
What is the risk level of Tata India Pharma & HealthCare Fund - Direct Plan Growth?
What is the minimum investment amount for Tata India Pharma & HealthCare Fund - Direct Plan Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article